Literature DB >> 3076412

T- and B-cell recognition of hepatitis B viral antigens.

D R Milich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3076412     DOI： 10.1016/0167-5699(88)91239-X

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  33 in total

1.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Distinct regulation of humoral and cellular immunities to hepatitis B surface antigen.

Authors:  H Y Lei; S C Lee; C K Yu
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.

Authors:  Wei-Guo Hu; Jun Wei; Heng-Chuan Xia; Xin-Xiu Yang; Feng Li; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 4.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

5.  A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibodies and T cell responses in mice.

Authors:  Xiaodan Cai; Weihao Zheng; Shaokun Pan; Shengyuan Zhang; Youhua Xie; Haitao Guo; Guoxin Wang; Zigang Li; Ming Luo
Journal:  Antiviral Res       Date:  2017-11-10       Impact factor: 5.970

Review 6.  Drug-induced "allergic hepatitis".

Authors:  P Podevin; M Biour
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

7.  B cells do not present antigen covalently linked to microspheres.

Authors:  A Galelli; B Charlot; E Dériaud; C Leclerc
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

8.  Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; D Ou; P Chong; S Gillam
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

9.  Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.

Authors:  F Schödel; S M Kelly; D L Peterson; D R Milich; R Curtiss
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 10.  The optimization of helper T lymphocyte (HTL) function in vaccine development.

Authors:  J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.